D89.0
Polyclonal hypergammaglobulinemia
Clinical Classification Guidelines
Inclusion Terms
- Benign hypergammaglobulinemic purpura
- Polyclonal gammopathy NOS
Medical Intelligence & Overview
Polyclonal hypergammaglobulinemia, classified under ICD-10 code D89.0, is a condition characterized by an increased level of immunoglobulins (antibodies) in the blood. Unlike monoclonal gammopathies, which involve a single clone of abnormal cells, this condition involves multiple immune cell lineages producing diverse immunoglobulins. It is generally considered benign but indicates an active immune response or inflammation within the body.
Causes & Symptoms
Clinical Causes: Chronic infections such as hepatitis, tuberculosis, or other bacterial and viral infections Autoimmune disorders like rheumatoid arthritis or lupus Chronic inflammatory states Certain liver diseases Other benign immune responses
Key Symptoms: Often no specific symptoms are present Skin rashes or purpura (purple spots on the skin) Swelling or enlarged lymph nodes Fatigue or general malaise Signs of underlying conditions, such as joint pain or fever
Diagnostic & Treatment
Diagnosis Path: Diagnosis is typically based on blood tests that reveal elevated levels of polyclonal immunoglobulins. Further investigations may include:
Treatment Protocols: Since polyclonal hypergammaglobulinemia is often a manifestation of another condition, management usually focuses on treating the underlying cause. Specific treatments may include:
Clinical Advice & FAQs
Billing Guidance
Is D89.0 a billable ICD-10 code?
Yes, D89.0 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report D89.0?
Clinical documentation must specify the nature of Polyclonal hypergammaglobulinemia and any associated comorbidities for accurate reporting.
Cite this Clinical Reference